AnxietyNCT07908771
Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section
A study testing Virtual Reality Distraction in people with Anxiety and Cesarean Section, run by Tarsus University at 1 site in Turkey (Türkiye).
Trial summary
This study will examine whether virtual reality during planned cesarean birth reduces women's anxiety and improves their satisfaction with the birth experience. The study will include 144 women undergoing elective cesarean section under spinal anesthesia at Adana City Training and Research Hospital in Türkiye. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Anxiety, Cesarean Section, Birth Satisfaction
- What is being tested?
- Virtual Reality Distraction
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 144 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Nov 2026to 30 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Women scheduled for elective cesarean section
- Singleton pregnancy
- Term pregnancy (≥37 weeks of gestation)
- Cesarean section planned under spinal anesthesia
- Aged 18 years or older
- Able to read, write and communicate in Turkish
- Voluntary participation and written informed consent
Who cannot join
- Intrauterine fetal death
- Major fetal congenital anomaly
- Failed spinal anesthesia requiring conversion to general anesthesia, or planned general anesthesia
- Visual or hearing impairment preventing use of virtual reality
- History of epilepsy, vertigo or motion sickness
- Diagnosed psychiatric disorder or regular use of anxiolytic/antidepressant medication
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Adana City Training and Research Hospital
Adana, Adana, 01370
Kübra Bozkurt, Bsc, +90.322 455 90 00, ankgungork13@gmail.com
About this study
Official title: The Effect of an Intraoperative Virtual Reality Intervention on State Anxiety and Cesarean Birth Satisfaction in Women Undergoing Elective Cesarean Section: A Randomized Controlled Trial
This study will examine whether virtual reality during planned cesarean birth reduces women's anxiety and improves their satisfaction with the birth experience.
The study will include 144 women undergoing elective cesarean section under spinal anesthesia at Adana City Training and Research Hospital in Türkiye. Participants will be randomly assigned to one of two groups. One group will receive routine care and watch a relaxing nature video with natural sounds through a virtual reality headset during surgery. The other group will receive routine care alone.
Read more
Virtual reality will be paused when the baby is born so that anxiety can be assessed and the mother can see her baby. It will then resume until surgery ends.
Anxiety and vital signs will be assessed before surgery and 15-30 minutes after completion of surgery, once the participant is clinically stable. An additional brief anxiety assessment will be performed immediately after birth, before the mother first sees her baby. Satisfaction with cesarean birth will be assessed 6-8 hours after birth.
The researchers will compare the results between the two groups to evaluate the effects of virtual reality on maternal anxiety and cesarean birth satisfaction.
Read the detailed description
This single-center, two-arm, parallel-group randomized controlled trial will evaluate an intraoperative virtual reality intervention in women undergoing elective cesarean section under spinal anesthesia. The planned sample is 144 women, with 72 participants assigned to each group.
Randomization and Allocation Concealment A computer-generated randomization sequence with a 1:1 allocation ratio and variable block sizes of four and six has been generated using Sealed Envelope. The sequence will be held by an independent person who is not involved in participant recruitment or intervention delivery. Sequentially numbered, opaque, sealed envelopes will be prepared before recruitment. After eligibility confirmation, written informed consent, and baseline assessments, the next envelope in numerical order will be opened to determine group assignment.
Intervention Virtual reality will begin after the effectiveness of spinal anesthesia has been confirmed. Participants will view the same standardized 360-degree nature video featuring forest, water, and wildlife scenes with natural sounds, without speech or guided meditation. The video lasts approximately 20-30 minutes and will be restarted if necessary.
At the baby's birth, virtual reality will be paused. The Face Anxiety Scale will be administered immediately after birth and before the mother's first meeting with her baby. After this assessment, routine newborn care and the mother's opportunity to see her baby will take place. Virtual reality will then resume until the end of surgery.
The control group will receive routine care alone, with assessments at the same time points.
Assessments State anxiety will be assessed using the State-Trait Anxiety Inventory, State Subscale (STAI-I), before surgery (prior to randomization) and 15-30 minutes after completion of surgery, once the participant is clinically stable.
The Face Anxiety Scale will be administered at three time points: before surgery (prior to randomization), immediately after birth and before the mother's first meeting with her baby, and 15-30 minutes after completion of surgery, once clinically stable.
Systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation will be recorded before surgery (prior to randomization) and 15-30 minutes after completion of surgery, once the participant is clinically stable.
Cesarean birth satisfaction will be assessed 6-8 hours postpartum using the Cesarean Birth Satisfaction Scale.
Masking Participants and the researcher delivering the intervention cannot be blinded. Data entry will be performed by an independent researcher unaware of group assignments, using groups coded as A and B. Statistical analyses will be conducted by a statistician unaware of which intervention each code represents. Group identities will be disclosed after the analyses are completed.
Statistical Analysis Data will be analyzed using appropriate statistical methods according to the measurement level and distribution of each outcome. The primary outcome, postoperative state anxiety, will be compared between groups with adjustment for baseline anxiety scores. Repeated measurements of Face Anxiety Scale scores will be analyzed using methods appropriate for ordinal longitudinal data. Vital signs will be compared between groups with adjustment for baseline measurements. Cesarean birth satisfaction scores will be compared between groups using appropriate statistical tests. Results will be reported with 95% confidence intervals and relevant effect size estimates. Statistical significance will be set at p < 0.05. Missing data will be assessed and reported.
- Conditions
- Anxiety, Cesarean Section, Birth Satisfaction
- Being tested
- Virtual Reality Distraction
- Keywords
- Virtual Reality, Elective Cesarean Section, State Anxiety, Cesarean Birth Satisfaction
- Medical subject headings
- Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual Reality DistractionDevice
Participants in the intervention group will receive a standardized immersive virtual reality (VR) session via a head-mounted display with headphones during elective cesarean section under spinal anesthesia, in addition to routine care. The VR headset will be applied after adequate spinal block is confirmed. Content is a 360-degree nature video (forest, water and wildlife scenes) with natural sounds, without speech or guided meditation, lasting about 20-30 minutes and restarted if surgery lasts longer. VR will be paused at the birth of the baby for the intraoperative Face Anxiety Scale assessment and the first mother-infant contact, then resumed until the end of surgery. Volume and fit will be adjusted for comfort. VR will be stopped immediately if dizziness, nausea, headache or other discomfort occurs, or if clinically required.
| Study group | Role | What they receive |
|---|---|---|
| Virtual Reality Plus Routine Care | Experimental | Participants will receive intraoperative virtual reality in addition to routine care during elective cesarean section under spinal anesthesia. After effective spinal anesthesia is confirmed, a standardized 360-degree nature video with natural sounds will be presented through a virtual reality headset. The intervention will be paused at birth for the Face Anxiety Scale assessment and the mother's first meeting with her baby, then resumed until surgery ends. Receives: Device: Virtual Reality Distraction |
| Routine Care | No intervention | Participants will receive routine care during elective cesarean section under spinal anesthesia, without virtual reality or any additional study intervention. Assessments will be performed at the same time points as in the experimental group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
State Anxiety
State anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-I), Turkish version. Scores range from 20 to 80; higher scores indicate higher anxiety levels.
Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Secondary outcomes (7)
Face Anxiety Score
Momentary anxiety will be assessed using the single-item Face Anxiety Scale (Turkish version). Scores range from 1 to 5; higher scores indicate higher anxiety.
Measured: Preoperatively (before randomization), intraoperatively (immediately after birth, before first mother-infant contact), and 15-30 minutes after completion of surgery, once clinically stable
Cesarean Birth Satisfaction
Cesarean birth satisfaction will be assessed using the 11-item Cesarean Birth Satisfaction Scale. Scores range from 11 to 55; higher scores indicate greater satisfaction.
Measured: 6-8 hours postpartum
Systolic Blood Pressure
Systolic blood pressure (mmHg) will be measured and recorded on the Vital Signs Monitoring Form.
Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Diastolic Blood Pressure
Diastolic blood pressure (mmHg) will be measured and recorded on the Vital Signs Monitoring Form.
Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Heart Rate
Heart rate (beats per minute) will be measured and recorded on the Vital Signs Monitoring Form.
Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Respiratory Rate
Respiratory rate (breaths per minute) will be measured and recorded on the Vital Signs Monitoring Form.
Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Peripheral Oxygen Saturation (SpO₂)
Peripheral oxygen saturation (%) will be measured by pulse oximetry and recorded on the Vital Signs Monitoring Form.
Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Nov 2026
- Study startNov 2026 (estimated)
- Primary completion30 Apr 2027 (estimated)
- Study completion30 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two-arm, parallel-group randomized controlled trial. Participants will be assigned in a 1:1 ratio to intraoperative virtual reality plus routine care or routine care alone, using variable block randomization.
- Masking
- None (open label)
- Enrolment
- 144 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tarsus University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ayşe ŞENOĞLU, Tarsus University
- Investigators
- Ayşe ŞENOĞLU, PhD, Principal investigator, Tarsus University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07908771
- Sponsor's protocol ID
- Tarsus-Kubra-VR-2026
- Status last verified
- Oct 2026
- First submitted
- 25 Oct 2026
- Last updated
- 2 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared publicly in order to protect participant confidentiality, in accordance with the Turkish Personal Data Protection Law (KVKK, No. 6698) and the informed consent obtained, which does not include permission for data sharing with third parties. Aggregated results will be reported in the thesis and in peer-reviewed publications.
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of an Intraoperative Virtual Reality Intervention on State Anxiety and Cesarean Birth Satisfaction in Women Undergoing Elective Cesarean Section: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07908771
- Acronym / sponsor ID
- Tarsus-Kubra-VR-2026
- Conditions
- Anxiety, Cesarean Section, Birth Satisfaction
- Keywords
- Virtual Reality, Elective Cesarean Section, State Anxiety, Cesarean Birth Satisfaction
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 144 participants (estimated)
- Lead sponsor
- Tarsus UniversityUniversity, hospital or other
- Study start
- Nov 2026 (estimated)
- Primary completion
- 30 Apr 2027 (estimated)
- Study completion
- 30 Apr 2027 (estimated)
- First posted
- 2 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will examine whether virtual reality during planned cesarean birth reduces women's anxiety and improves their satisfaction with the birth experience.
The study will include 144 women undergoing elective cesarean section under spinal anesthesia at Adana City Training and Research Hospital in Türkiye. Participants will be randomly assigned to one of two groups. One group will receive routine care and watch a relaxing nature video with natural sounds through a virtual reality headset during surgery. The other group will receive routine care alone.
Virtual reality will be paused when the baby is born so that anxiety can be assessed and the mother can see her baby. It will then resume until surgery ends.
Anxiety and vital signs will be assessed before surgery and 15-30 minutes after completion of surgery, once the participant is clinically stable. An additional brief anxiety assessment will be performed immediately after birth, before the mother first sees her baby. Satisfaction with cesarean birth will be assessed 6-8 hours after birth.
The researchers will compare the results between the two groups to evaluate the effects of virtual reality on maternal anxiety and cesarean birth satisfaction.
Detailed description
This single-center, two-arm, parallel-group randomized controlled trial will evaluate an intraoperative virtual reality intervention in women undergoing elective cesarean section under spinal anesthesia. The planned sample is 144 women, with 72 participants assigned to each group.
Randomization and Allocation Concealment A computer-generated randomization sequence with a 1:1 allocation ratio and variable block sizes of four and six has been generated using Sealed Envelope. The sequence will be held by an independent person who is not involved in participant recruitment or intervention delivery. Sequentially numbered, opaque, sealed envelopes will be prepared before recruitment. After eligibility confirmation, written informed consent, and baseline assessments, the next envelope in numerical order will be opened to determine group assignment.
Intervention Virtual reality will begin after the effectiveness of spinal anesthesia has been confirmed. Participants will view the same standardized 360-degree nature video featuring forest, water, and wildlife scenes with natural sounds, without speech or guided meditation. The video lasts approximately 20-30 minutes and will be restarted if necessary.
At the baby's birth, virtual reality will be paused. The Face Anxiety Scale will be administered immediately after birth and before the mother's first meeting with her baby. After this assessment, routine newborn care and the mother's opportunity to see her baby will take place. Virtual reality will then resume until the end of surgery.
The control group will receive routine care alone, with assessments at the same time points.
Assessments State anxiety will be assessed using the State-Trait Anxiety Inventory, State Subscale (STAI-I), before surgery (prior to randomization) and 15-30 minutes after completion of surgery, once the participant is clinically stable.
The Face Anxiety Scale will be administered at three time points: before surgery (prior to randomization), immediately after birth and before the mother's first meeting with her baby, and 15-30 minutes after completion of surgery, once clinically stable.
Systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation will be recorded before surgery (prior to randomization) and 15-30 minutes after completion of surgery, once the participant is clinically stable.
Cesarean birth satisfaction will be assessed 6-8 hours postpartum using the Cesarean Birth Satisfaction Scale.
Masking Participants and the researcher delivering the intervention cannot be blinded. Data entry will be performed by an independent researcher unaware of group assignments, using groups coded as A and B. Statistical analyses will be conducted by a statistician unaware of which intervention each code represents. Group identities will be disclosed after the analyses are completed.
Statistical Analysis Data will be analyzed using appropriate statistical methods according to the measurement level and distribution of each outcome. The primary outcome, postoperative state anxiety, will be compared between groups with adjustment for baseline anxiety scores. Repeated measurements of Face Anxiety Scale scores will be analyzed using methods appropriate for ordinal longitudinal data. Vital signs will be compared between groups with adjustment for baseline measurements. Cesarean birth satisfaction scores will be compared between groups using appropriate statistical tests. Results will be reported with 95% confidence intervals and relevant effect size estimates. Statistical significance will be set at p < 0.05. Missing data will be assessed and reported.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two-arm, parallel-group randomized controlled trial. Participants will be assigned in a 1:1 ratio to intraoperative virtual reality plus routine care or routine care alone, using variable block randomization.
| Arm | Type | Receives |
|---|---|---|
| Virtual Reality Plus Routine Care | Experimental | Device: Virtual Reality DistractionParticipants will receive intraoperative virtual reality in addition to routine care during elective cesarean section under spinal anesthesia. After effective spinal anesthesia is confirmed, a standardized 360-degree nature video with natural sounds will be presented through a virtual reality headset. The intervention will be paused at birth for the Face Anxiety Scale assessment and the mother's first meeting with her baby, then resumed until surgery ends. |
| Routine Care | No intervention | –Participants will receive routine care during elective cesarean section under spinal anesthesia, without virtual reality or any additional study intervention. Assessments will be performed at the same time points as in the experimental group. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Women scheduled for elective cesarean section
- Singleton pregnancy
- Term pregnancy (≥37 weeks of gestation)
- Cesarean section planned under spinal anesthesia
- Aged 18 years or older
Key exclusion criteria (6 listed)
- Intrauterine fetal death
- Major fetal congenital anomaly
- Failed spinal anesthesia requiring conversion to general anesthesia, or planned general anesthesia
- Visual or hearing impairment preventing use of virtual reality
- History of epilepsy, vertigo or motion sickness
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual Reality DistractionParticipants in the intervention group will receive a standardized immersive virtual reality (VR) session via a head-mounted display with headphones during elective cesarean section under spinal anesthesia, in addition to routine care. The VR headset will be applied after adequate spinal block is confirmed. Content is a 360-degree nature video (forest, water and wildlife scenes) with natural sounds, without speech or guided meditation, lasting about 20-30 minutes and restarted if surgery lasts longer. VR will be paused at the birth of the baby for the intraoperative Face Anxiety Scale assessment and the first mother-infant contact, then resumed until the end of surgery. Volume and fit will be adjusted for comfort. VR will be stopped immediately if dizziness, nausea, headache or other discomfort occurs, or if clinically required. | Device | Virtual Reality Plus Routine Care |
Primary outcome
State Anxiety
Time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
State anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-I), Turkish version. Scores range from 20 to 80; higher scores indicate higher anxiety levels.
7 secondary outcomes
Face Anxiety Score
Time frame: Preoperatively (before randomization), intraoperatively (immediately after birth, before first mother-infant contact), and 15-30 minutes after completion of surgery, once clinically stable
Cesarean Birth Satisfaction
Time frame: 6-8 hours postpartum
Systolic Blood Pressure
Time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Diastolic Blood Pressure
Time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Heart Rate
Time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Respiratory Rate
Time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Peripheral Oxygen Saturation (SpO₂)
Time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared publicly in order to protect participant confidentiality, in accordance with the Turkish Personal Data Protection Law (KVKK, No. 6698) and the informed consent obtained, which does not include permission for data sharing with third parties. Aggregated results will be reported in the thesis and in peer-reviewed publications.
Related trials for Anxiety
Recruiting
Marine Lipids Ease Painful TMD
Temporomandibular Disorder (TMD)
Not yet recruitingObservational study
Soap-and-Water Bed Bath Versus Disposable Wipe Bath in the Same ICU Patients
Critical Illness, Pain
Recruiting
Peer-Mentor Support for Vulnerable Patients With Atrial Fibrillation
Atrial Fibrillation
Not yet recruiting
Effects of Oxygen Cage Support During Cataract Surgery
Cataract
Not yet recruiting
Feasibility of a Web-based Single-session Intervention Combined With Ecological Momentary Assessment and Intervention for Patients With Complex Posttraumatic Stress Disorder Awaiting Inpatient Treatment
PTSD - Post Traumatic Stress Disorder, Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ayşe ŞENOĞLU, PhD principal investigator
Tarsus University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual Reality Distraction in people with Anxiety and Cesarean Section, run by Tarsus University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ayşe ŞENOĞLU, PhD (90 (324) 600 00 33 ext. 2226, aysesenoglu@tarsus.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
State Anxiety (time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.